Biopharma manufacturing, improve industrial supply chain to address shortages, advance technology, improve patient outcomes.
2025 · 4th Quarter (Oct 1 - Dec 31)
MONTICELLO GROUP, LLC ON BEHALF OF DETROIT BIOPHARMA
Filed by KAMRAN DARAVI CONSULTING LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Jan 29, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- KAMRAN DARAVI CONSULTING LLC
- Filing UUID
- b373a3a2-512f-4dca-95e1-614b2d1ad814
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Biopharma manufacturing, improve industrial supply chain to address shortages, advance technology, improve patient outcomes.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.